Xilio Therapeutics (XLO) EBIT (QoQ) (2020 - 2026)
Xilio Therapeutics (XLO) EBIT (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 468.11 Bn | 463.32 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.48 Bn | 115.23 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.55 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - |
| 8 | Argenx Se | 55.66 Bn | 50.47 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.42 Bn | 34.41 Bn | 959.66 Mn |
| 10 | Xilio Therapeutics | 145.98 Mn | -4.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.23% |
| Dec 31, 2025 | -513.58% |
| Sep 30, 2025 | 86.57% |
| Jun 30, 2025 | -3.72% |
| Mar 31, 2025 | -1.63% |
| Dec 31, 2024 | 7.68% |
| Sep 30, 2024 | -0.39% |
| Jun 30, 2024 | 15.91% |
| Mar 31, 2024 | 3.55% |
| Dec 31, 2023 | -4.43% |
| Sep 30, 2023 | 13.70% |
| Jun 30, 2023 | 14.49% |
| Mar 31, 2023 | -1.55% |
| Dec 31, 2022 | -14.65% |
| Sep 30, 2022 | 17.70% |
| Jun 30, 2022 | -15.68% |
| Mar 31, 2022 | -8.53% |
| Dec 31, 2021 | -22.52% |
| Sep 30, 2021 | 30.63% |
| Jun 30, 2021 | -39.27% |